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Abstract
In this paper we present various pneumatically actuated microﬂuidic valves to enable user-deﬁned ﬂuid management within
a microﬂuidic chip. To identify a feasible valve design, certain valve concepts are simulated in ANSYS to investigate the
pressure dependent opening and closing characteristics of each design. The results are veriﬁed in a series of tests. Both
the microﬂuidic layer and the pneumatic layer are realized by means of soft-lithographic techniques. In this way, a network
of channels is fabricated in photoresist as a molding master. By casting these masters with PDMS (polydimethylsiloxane)
we get polymeric replicas containing the channel network. After a plasma-enhanced bonding process, the two layers are
irreversibly bonded to each other. The bonding is tight for pressures up to 2 bar. The valves are integrated into a microﬂuidic
cell handling system that is designed to manipulate cells in the presence of a liquid reagent (e.g. PEG – polyethylene glycol,
for cell fusion). For this purpose a user-deﬁned ﬂuid management system is developed. The ﬁrst test series with human cell
lines show that the microﬂuidic chip is suitable for accumulating cells within a reaction chamber, where they can be ﬂushed
by a liquid medium.
Keywords: microﬂuidic chip, valve, cell handling, simulation, pneumatic actuation, polydimethylsiloxane.
1 Introduction
The integration of new characteristics into a cellular
system is an essential challenge in modern biotechnol-
ogy. Methods which are suitable for fusing diﬀerent
cell types to generate hybrid cells which show hybrid
characteristics of the two original cells are of central in-
terest in this area. The hybridoma technology, for ex-
ample, generates hybrid cell lines by fusing antibody-
producing B-cells with a cancerous myeloma cell line.
As a result of this fusion, the generated hybridomas
produce monoclonal antibodies. Cells can be fused
for example chemically in the presence of polyethylene
glycol (PEG), electrically by the application of pulsed
electric ﬁelds (electrofusion), or by means of a focused
laser beam (laser-induced fusion). Fusion is tradition-
ally performed in a cell bulk of two mixed cell lines.
The drawback of this traditional type of cell fusion
within a bulk is the statistical combination of the cells.
Equal concentrations in both cell suspensions will lead
to 50 % heterokaryon formation (fusion of two diﬀerent
cell types) and 50 % monokaryon formation (fusion of
cells of the same type). User-controlled and observable
cell fusion is not realizable with this method. In recent
years, the use of microﬂuidic systems has become an el-
igible method for applications like biochemical assays,
medical diagnostics, drug delivery, cell sorting and cell
manipulation, as they enable transportation, isolation
and manipulation of small amounts of liquids and cells
or even single cells. This microﬂuidic system enables
the user to select certain cells which should be manip-
ulated or investigated. Polydimethylsiloxane (PDMS)
is a well suited material for these applications, as mi-
croﬂuidic systems can be developed very cheaply and
rapidly by methods of soft lithography [1, 2].
Fig. 1: Common geometrical parameters of all valve types
2 Materials and methods
2.1 Valve design
Various valve concepts were designed and fabricated in
PDMS using soft-lithographic techniques to ﬁnd a fea-
sible geometry. The geometry of the pneumatic layer
is equal in all investigated valve types, as is the width
and height of the ﬂuidic channel. The changes are
only in the form of the ﬂuidic channel (rectangular
or rounded) and the order of the two functional layers
(Fig. 2, 3, 4, 5). Figure 1 shows the general geometrical
parameters of all investigated valve types. The pneu-
matic chamber has a diameter of 1 mm. The height
of the chamber is 70 μm. A change in height has no
inﬂuence on the characteristics of the valve, as long
as it is high enough to make upward bending of the
membrane possible. The cross-section of the ﬂuidic
channel is 200μm× 40μm. The membrane is 50 μm
in thickness. The ﬁrst valve geometry (valve type 1)
was built up with an interrupted microﬂuidic chan-
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nel and a pneumatic chamber above the interruption
(Fig. 2) similar to [3, 4]. The bar is 30 μm in width.
This valve was at ﬁrst operated passively, i.e. no
pressure (positive or negative) was applied to the
pneumatic layer. With no pressure diﬀerence between
the pneumatic layer and the ﬂuidic layer, the bar
blocks the ﬂow and the valve remains closed. There-
fore valve type 1 is intrinsically closed. When pressure
is applied to the ﬁlled microﬂuidic channel, the mem-
brane around the interruption lifts up and the ﬂuid is
able to pass the valve. This is the open state of the
valve. To optimize this concept the valve was oper-
ated actively by applying a positive or negative pres-
sure onto the pneumatic chamber. The second valve
geometry (valve type 2) was designed without the in-
tersection in the ﬂuidic channel, using a microﬂuidic
channel with just a rectangular cross-section (Fig. 3).
Fig. 2: Valve type 1. Cross-section of valve area with inter-
rupted ﬂuidic channel. 1: pneumatic layer; 2: ﬂuidic layer;
3: substrate
Fig. 3: Valve type 2. Cross-section of valve area with rect-
angular channel geometry. 1: pneumatic layer; 2: ﬂuidic
layer; 3: substrate
This valve type can only work when actively ac-
tuated, because it is intrinsically open. To avoid the
disadvantages of valve type 2, which are explained in
detail in the results, we designed a subtype of this
geometry. This optimized valve type 3 is character-
ized by a ﬂuidic channel with a rounded cross-section
(Fig. 4). The rounded geometry of the ﬂuidic channel
is realized by heating the photoresist master to 140 ◦C
for 5 minutes, similar to [5]. For further optimization
based on the ANSYS simulations, we designed a valve
type 4 similar to type 3. It is also characterized by
a rounded ﬂuidic cross-section. The signiﬁcant diﬀer-
ence is the reverse order of the PDMS layers (Fig. 5).
The pneumatic layer is now below the ﬂuidic channel.
Fig. 4: Valve type 3. Cross-section of valve area with round
channel geometry. 1: pneumatic layer; 2: ﬂuidic layer; 3:
substrate
Fig. 5: Valve type 4. Cross-section of valve area with
round channel geometry. 1: pneumatic layer; 2: ﬂuidic
layer; 3: substrate
2.2 Fabrication
The fabrication of the microﬂuidic chip starts with the
design of a microﬂuidic and pneumatic channel system
using CAD software. This layout is then printed in
25 kdpi to a transparency which acts as a photomask in
photolithography to structure AZ nLof / AZ 9260 pho-
toresist (AZ Electronic Materials) on a silicon wafer.
By casting liquid polymer onto the master wafer the
channel network is transferred to the PDMS device.
The PDMS (Sylgard 184, Dow Corning) is a two-
component system consisting of a base and a curing
agent, which are mixed in a ratio of 10:1 (base:curing
agent). Subsequently, the liquid pre-polymer is poured
onto the master and is cured in a convection oven at
80 ◦C for 20 minutes. Afterwards, the PDMS replica
can be peeled oﬀ from the wafer. The channel system
can be made accessible by punching out holes into the
PDMS slide using a hollow needle. The cast PDMS
layers can be bonded in two ways. Bringing the poly-
mer substrates into tight contact without a pretreat-
ment leads to reversible bonding of the two slabs due
to van der Waals forces [1, 2]. Because this kind of
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bonding does not withstand elevated pressures> 0.4
bar in the channel network, we prefer plasma enhanced
bonding of the substrates. If the PDMS devices are
exposed to an O2-plasma, covalent Si–O–Si bonds are
generated, leading to irreversible, tight bonding up to
pressures of about 2 bar [2, 6, 7]. The plasma pretreat-
ment is performed in a plasma asher with 275 W at
13.56 MHz, 420 sccm O2, 2 mbar for 12 s (Tegal Plas-
maline 415). The device is ﬁnally bonded to another
PDMS layer or to a glass substrate to seal the remain-
ing open channels, utilizing the same plasma process
(Fig. 2, 3, 4, 5).
2.3 Microﬂuidic chip
The valves are integrated into a microﬂuidic chip. The
actual chip layout consists of three ﬂuidic inlet chan-
nels (e.g. cell solution 1, cell solution 2, liquid reagent),
one outlet channel and two backﬂush channels with an
inlet and an outlet for both (Fig. 6). Each channel is
equipped with a pneumatically actuated valve to open
or close the ﬂuid channel (Fig. 7).
Fig. 6: Microﬂuidic network with inlet and outlet channels,
backﬂush channels and pneumatic valves
Fig. 7: Pneumatically actuated valves over ﬂuid channels
Two driving mechanisms were investigated for the
actuation principle for the cell solution. An actuation
mechanism utilizing a peristaltic pump was not feasi-
ble due to the low survival rate of the cells due to the
mechanical components of the peristaltic pump. Be-
cause of these restrictions, a software-controlled pneu-
matical driving mechanism was developed which actu-
ates the pneumatic layer as well as the ﬂuidic layer.
Therefore the whole chip is integrated into an adapter
that makes all ﬂuidic and pneumatic channels accessi-
ble. A centralized valve group supplied with pressur-
ized air is connected to the adapter. The valve group
itself is computer controllable. By using a LABVIEW-
based interface, user-deﬁned ﬂuid management is pos-
sible (Fig. 8). The reaction chamber itself consists of
a beaked structure including a centered passage 5 μm
in height (Fig. 9). This design is suitable for accumu-
lating cells in the middle of the chamber and bringing
them into tight contact. At the same time, it enables
a gentle ﬂuid stream, which is necessary for transport-
ing more cell solution or another liquid medium into
the chamber.
Fig. 8: Experimental setup with a microﬂuidic chip
mounted on an adapter. The adapter is pneumatically
connected via a centralized and software-controlled valve
group
Fig. 9: Reaction chamber. Cells can be accumulated in the
central structure
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A typical cell accumulation process consists of the
following steps:
1. Open the valve of the exit channel
2. Open the valve of inlet 1 and pump cell solution 1
3. Close the valve of inlet 1
4. Open the valve of inlet 2 and pump cell solution 2
5. Close the valve of inlet 2
6. Open the valve of inlet 3 to ﬂush the accumulated
cells with reagent
7. Close the valves of inlet 3 and exit channel
8. Open the valves of one backﬂush channel and
pump the cells out of the chip
2.4 Cell lines
In order to analyze the suitability of the microﬂuidic
chip for cell handling, permanent cell lines were iden-
tiﬁed, which were comparable in size and handling to
the ﬁnal target cells which should be merged within
the chip. The human myeloid cell line U937 and the
human lymphoid cell line L540 were found to meet
these requirements. This avoids laborious prepara-
tion of spleen cells from mice and animal consuming
procedures for the preliminary experiments. Passages
through microﬂuidic structures may aﬀect cell func-
tions, e.g. by mechanical stress or adherence depen-
dent activation. The viability of the cells after passage
of the microﬂuidic was tested by viability and prolif-
eration assays.
3 Results
3.1 Valve simulations
All valve concepts were simulated using ANSYS to op-
timize the geometries. Valve type 1 was at ﬁrst just
operated passively. This means that the pneumatic
chamber is not pressurized and the membrane just
bends up and down depending on the pressure in the
ﬂuidic channel. This concept is optimized by applying
a positive or negative pressure to the pneumatic layer.
With increasing pressure in the pneumatic chamber
in the closed state the bar can be pressed down even
more strongly, leading to eﬀective sealing of the ﬂuidic
channel that blocks the ﬂow. In the opened state, a
relative negative pressure of 0.2 bar in the pneumatic
layer results in upward bending of the membrane and
the bar, enabling continuous ﬂow. Because the bar is
linked at the sides of the channel, increasing negative
pressure does not improve the valve opening signiﬁ-
cantly. With about 15 μm in the central region of
the valve the opened cross-section of this valve type is
clearly smaller than the channel itself, as can be seen
in the ANSYS simulations (Fig. 10, 11).
Figures 12, 13 and 14 show the simulation results
for valve type 2. When the pneumatic layer is not pres-
surized, continuous ﬂow is possible in the ﬂuidic chan-
nel and the valve is intrinsically open. In this state,
Fig. 10: ANSYS simulation of valve type 1 in the opened
state when actuated with a negative pressure of 0.2 bar in
the pneumatic layer
Fig. 11: ANSYS simulation of valve type 1 in the opened
state when actuated with negative pressure of 0.2 bar in
the pneumatic layer. Perspective from inside the channel
Fig. 12: ANSYS simulation of valve type 2 in the closed
state when actuated with 0.5 bar in the pneumatic layer
the opening cross-section of the valve is the same as
the channel cross-section itself, allowing undisturbed
ﬂow. If pressure is applied to the pneumatic layer, the
membrane bends downwards and blocks the channel
so that the valve is in the closed state. The ANSYS
simulations show insuﬃcient closure of valve type 2
(Fig. 13, 14).
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Fig. 13: ANSYS simulation of valve type 2 in the closed
state when actuated with 0.5 bar in the pneumatic layer.
Perspective from inside the channel
Fig. 14: ANSYS simulation of valve type 2 in the closed
state when actuated with 1.0 bar in the pneumatic layer.
Perspective from inside the channel
Due to the rectangular ﬂuidic channel, the mem-
brane cannot bent entirely to the bottom of the chan-
nel. The simulations show two remaining approxi-
mately triangular areas where ﬂow is still possible. In
the middle of the channel the closure of the valve is
complete. Depending on the pressure applied to the
pneumatic layer, a greater or smaller amount of ﬂuid
is able to pass the valve. Figure 14 shows that an
entire stop to the ﬂuid cannot be obtained within an
acceptable pressure range (< 1 bar). These imper-
fect closing characteristics also persist if the pressure
is increased up to 2 bar. In the same pressure region,
valve type 3 shows better sealing than valve type 2,
but no complete ﬂow blockage can be achieved with
this modiﬁcation (Fig. 15).
Figure 16 shows the results of the ANSYS sim-
ulations for valve type 4. This valve type is char-
acterized by a reverse order of the functional layers,
as described above. The reverse order results in a
membrane which, when actuated by pressure, tightly
adapts to the rounded ﬂuidic channel, resulting in re-
Fig. 15: ANSYS simulation of valve type 3 in the closed
state when actuated with 0.5 bar in the pneumatic layer.
Perspective from inside the channel
Fig. 16: ANSYS simulation of valve type 4 in the closed
state when actuated with 0.75 bar in the pneumatic layer
liable sealing. The ANSYS simulations show eﬀective
closure of this valve type for pressures < 1 bar. In
summary, the simulations show that valve types 2 and
3 are not suitable geometries for reliable ﬂuid man-
agement. These results were veriﬁed in several exper-
imental test series. Valve types 2 and 3 show blocked
ﬂow in the middle of the channel. With increasing
pressure on the pneumatic layer the closed area of the
channel also increases. However, a persistent ﬂowrate
is observable in these geometries at the sides of the
channel, which cannot be blocked despite an pressure
increase of up to 2 bar in the pneumatic layer. By con-
trast, the simulations indicate that valve types 1 and
4 are adequate designs for a well working valve. Pri-
marily valve type 4 shows excellent properties in the
opened state. The cross-section of the valve in this
state is the entire cross-section of the ﬂuidic channel.
The ﬂow does not need to pass a constriction caus-
ing high shear rates, as in type 1. In the closed state,
valve type 4 entirely blocks the ﬂow when a pressure of
about 0.75–1 bar is applied to the pneumatic chamber.
In the test series, valve type 4 showed one disadvan-
45
Acta Polytechnica Vol. 50 No. 4/2010
tage concerning the integrity of the valve. Due to the
stiﬀness of PDMS, the membrane of the pneumatic
channel must not exceed a thickness of about 50 μm.
This is necessary because the membrane is distorted
when the valve is actuated and has to apply tightly
to the rounded wall of the ﬂuidic channel. An exces-
sively thick membrane limits this distortion and the
valve does not entirely block the ﬂow. Due to the low
thickness of the membrane, it can be damaged. Care-
ful handling during casting and the whole assembly
process is therefore essential. Valve type 1 shows clear
advantages concerning the closed state. Its intrinsic
closing behavior is already very eﬃcient, and the seal-
ing can be further optimized by a little overpressure
in the pneumatic chamber. The disadvantage of valve
type 1 is its reduced cross-section in the opened state.
When actuated with negative pressure, the membrane
and the bar of the valve bend up only in the central
region. This produces just a small opening compared
to the whole cross-section of the ﬂuidic channel. The
test series showed that this is no serious problem when
dealing with particle-free solutions. When handling
solutions including particles like cells, however, this
problem causes obstruction of the valve if the parti-
cles are too big to pass the opened part of the channel.
This problem makes valve type 1 inapplicable for such
applications.
3.2 Biological tolerance
The compatibility of the microﬂuidic chip for cells was
tested by viability and proliferation assays to exclude
a negative impact of the microﬂuidic passage on the
cells. No signiﬁcant diﬀerence in viability and prolif-
erating activity was observed. The suitability of the
diﬀerent valve designs for cell handling was tested us-
ing the human cell lines U937 and L540. Valve type
1 shows excellent results when dealing with cell-free
media such as buﬀer solutions. Unfortunately, cells
are generally damaged when passing the valve due to
the mechanical stress they are exposed to between the
lifted bar and the bottom of the ﬂuidic channel. The
test series for valve type 4 showed excellent suitability
for cell handling applications. No negative impact on
the cell survival rate is caused by this type of valve
geometry.
3.3 Cell accumulation
In the test series with human cell lines U937 and L540
we showed that the microﬂuidic chip is suitable for
user-deﬁned cell handling. We are able to collect one
or more cells within the reaction chamber (Fig. 17).
After collecting the cells we can ﬂush them with an
arbitrary liquid medium to initiate certain reactions
(e.g. cell fusions when using PEG as a medium). Af-
terwards, the cells can be ﬂushed out of the chip for
further biological investigations.
Fig. 17: Cell accumulation in the reaction chamber
4 Conclusions
In this paper we have simulated 4 pneumatically actu-
ated valve concepts, and we propose two of them (valve
type 1 and 4) as suitable for microﬂuidic applications
in PDMS substrates. The valve function has been sim-
ulated in ANSYS and the simulation results have been
veriﬁed in several test series. One valve type (valve
type 4) is shown to be very advantageous when deal-
ing with solutions with particles such as cells inside.
The other valve type (valve type 1) is proposed for mi-
croﬂuidic applications with particle-free solutions. By
integrating these valves into microﬂuidic channels we
designed a pneumatically actuated microﬂuidic chip
for cell handling applications. A software interface al-
lows a user-deﬁned ﬂuid management. The system de-
sign is suitable for collecting one or more cells within
a reaction chamber, where they can be ﬂushed with a
liquid medium to initiate biological reactions such as
cell fusion.
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